Fig. 3From: Treatment patterns, healthcare resource utilization, and costs among patients with idiopathic pulmonary fibrosis treated with antifibrotic medications in US-based commercial and Medicare Supplemental claims databases: a retrospective cohort studyAdjusted healthcare costs per-person per-month while persistent on antifibrotics. 1Predicted costs were estimated using the recycled prediction method and bootstrap resampling to estimate 95% CIsBack to article page